David Sinclair· PhD
Human umbilical cord plasma injected weekly into elderly subjects for 10 weeks reduced epigenetic age by an ave of 0.82 years & improved kidney function 😎
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Human umbilical cord plasma injected weekly into elderly subjects for 10 weeks reduced epigenetic age by an ave of 0.82 years & improved kidney function 😎
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
The work shows, for the first time, that plasma fraction treatment reduces the epigenetic age of multiple tissues, and not by a little.